Published in Obesity and Diabetes Week, May 12th, 2003
At the University of Vienna, Austria, researchers pitted the stepwise combination fasting plasma (blood) glucose and glycosylated hemoglobin for diabetes screening in hypertensive patients against the "gold standard" oral glucose tolerance test. Their findings were published in the American Journal of Hypertension.
"Diabetes in patients with high blood pressure is a highly dangerous combination," said Michael A. Weber, MD, an editor of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.